Aesica is to upgrade its API manufacturing capabilities to enable the company to manufacture high potency APIs at commercial scale. Following the upgrade, Aesica will be able to manufacture SafeBridge Category 3 API and formulated products from pilot to commercial scale at two of its sites in Europe.
Aesica
Wednesday, 8 February 2012
Aesica to expand HPAPI capabilities
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment